SCM
Sio Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-913,621
| Closed | -$2.42M | – | 77 |
|
|
2021
Q4 | $2.42M | Hold |
913,621
| – | – | 0.73% | 38 |
|
|
2021
Q3 | $3.32M | Buy |
913,621
+83,900
| +10% | +$305K | 1.06% | 30 |
|
|
2021
Q2 | $3.6M | Buy |
+829,721
| New | +$3.6M | 0.9% | 40 |
|
|
2019
Q2 | – | Sell |
-1,609,265
| Closed | -$4.14M | – | 77 |
|
|
2019
Q1 | $4.14M | Sell |
1,609,265
-571,281
| -26% | -$1.47M | 1.12% | 32 |
|
|
2018
Q4 | $5.02M | Buy |
2,180,546
+337,045
| +18% | +$775K | 1.83% | 18 |
|
|
2018
Q3 | $5.92M | Buy |
1,843,501
+444,883
| +32% | +$1.43M | 2.03% | 16 |
|
|
2018
Q2 | $3.96M | Buy |
+1,398,618
| New | +$3.96M | 2.19% | 15 |
|
|
2018
Q1 | – | Sell |
-885,055
| Closed | -$3.43M | – | 41 |
|
|
2017
Q4 | $3.43M | Sell |
885,055
-678,252
| -43% | -$2.63M | 1.94% | 11 |
|
|
2017
Q3 | $3.97M | Buy |
1,563,307
+217,584
| +16% | +$553K | 2.06% | 10 |
|
|
2017
Q2 | $3.67M | Sell |
1,345,723
-542,458
| -29% | -$1.48M | 1.75% | 14 |
|
|
2017
Q1 | $6.25M | Buy |
1,888,181
+624,791
| +49% | +$2.07M | 3.5% | 6 |
|
|
2016
Q4 | $3.01M | Buy |
1,263,390
+242,671
| +24% | +$578K | 1.75% | 14 |
|
|
2016
Q3 | $3.75M | Sell |
1,020,719
-312,977
| -23% | -$1.15M | 2.58% | 7 |
|
|
2016
Q2 | $2.97M | Sell |
1,333,696
-283,200
| -18% | -$632K | 1.52% | 12 |
|
|
2016
Q1 | $3.36M | Buy |
+1,616,896
| New | +$3.36M | 1.23% | 27 |
|